Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from HC Wainwright & Co

Expert Outlook: Ocular Therapeutix Through The Eyes Of 4 Analysts

Across the recent three months, 4 analysts have shared their insights on Ocular Therapeutix (NASDAQ:OCUL), expressing a variety of opinions spanning from bullish to bearish.

Beyond The Numbers: 5 Analysts Discuss Cleanspark Stock

Beyond The Numbers: 5 Analysts Discuss Cleanspark Stock

Analysts' ratings for Cleanspark (NASDAQ:CLSK) over the last quarter vary from bullish to bearish, as provided by 5 analysts.

Urban Outfitters To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Wednesday

Urban Outfitters To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Unpacking the Latest Options Trading Trends in Cassava Sciences

Deep-pocketed investors have adopted a bullish approach towards Cassava Sciences (NASDAQ:SAVA), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SAVA usually suggests something big is…

Benzinga's Top Ratings Upgrades, Downgrades For August 30, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

65 Biggest Movers From Yesterday

65 Biggest Movers From Yesterday

Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and $2 price target.

Organisations

Lockheed Martin

Urban Outfitters

Northrop Grumman

General Dynamics

B of A Securities

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play